Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01198834 · ClinicalTrials.gov registry record · Phase 3
MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Ankle Sprains
A Phase 3 study of Ankle Sprains, sponsored by MEDRx USA.
- Completed
- Registry status
- Phase 3
- Development phase
- 600
- Enrollment target
- 20
- Study locations
NCT01198834: Completed Phase 3 study of Ankle Sprains, sponsored by MEDRx USA.
NCT01198834 is a Phase 3 study of Ankle Sprains that has completed, run by MEDRx USA. The registered enrollment target is 600 participants, above the 109-participant average among 4 other Ankle Sprains trials with a reported enrollment target (450% higher). The trial reports 20 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01198834, a Phase 3 study of Ankle Sprains, has completed, sponsored by MEDRx USA.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 600 participants
- Enrollment target
- 20
- Study locations
Study Summary
A Randomized, Multi-Center, Double-Blind, Factorial, Comparator and Placebo-Controlled Phase III Trial to Evaluate the Efficacy, Tolerability and Safety of MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Ankle Sprains
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Lidocaine
- DRUG Etodolac
- DRUG MRX-7EAT
Study Locations (20)
Florida
- - Daytona Beach
- - Fort Lauderdale
- - Gulf Breeze
- - Orlando
- - West Palm Beach
Indiana
- - Avon
- - Fishers
- - Franklin
- - Greenfield
- - Muncie
California
- - Chico
- - Palm Springs
- - San Diego
Colorado
- - Aurora
- - Colorado Springs
- - Denver
Arizona
- - Phoenix
Arkansas
- - North Little Rock
Idaho
- - Boise
Iowa
- - Dubuque
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2010-09 |
| Est. Completion | 2011-06 |
| Phase | Phase 3 |
What the finished NCT01198834 record still lists
NCT01198834 is an interventional study that assigns participants to a tested intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, above the 109-participant average among 4 other Ankle Sprains trials with a reported enrollment target (450% higher).
The record links to 1 condition, with Ankle Sprains appearing as the primary indexed condition, and to 4 interventions - of which Placebo is the first listed.
NCT01198834 names 20 study sites across 8 states, led by Florida, Indiana, California.
Frequently Asked Questions
What is clinical trial NCT01198834 about?
NCT01198834 is a clinical study titled "MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Ankle Sprains". A Randomized, Multi-Center, Double-Blind, Factorial, Comparator and Placebo-Controlled Phase III Trial to Evaluate the Efficacy, Tolerability and Safety of MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Ankle Sprains
What is the current status of trial NCT01198834?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 600 participants. The study started on 2010-09. Estimated completion is 2011-06.
What conditions does trial NCT01198834 study?
This clinical trial studies the following conditions: Ankle Sprains.
What interventions are being tested in trial NCT01198834?
The interventions under investigation include: Placebo (DRUG), Lidocaine (DRUG), Etodolac (DRUG), MRX-7EAT (DRUG).
Who is sponsoring clinical trial NCT01198834?
This trial is sponsored by MEDRx USA, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01198834 being conducted?
This trial has 20 study locations across Arizona, Arkansas, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ankle Sprains
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Addressing Neuromuscular Deficits for Improved Outcomes in Ankle Rehabilitation
RECRUITING · NA
-
Auditory Biofeedback Gait Training Individuals With Chronic Ankle Instability
RECRUITING · NA
-
Ankle Instability Using Foot Intensive Rehabilitation
ACTIVE NOT RECRUITING · NA
-
Cognitive Behavioral Based Physical Therapy for Patients With Chronic Ankle Instability
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia